Answers are grounded in this paper and cite their sources.
Good morning. Two setups on the board before the open. First, SPY long — entry four hundred forty-two fifty, target four forty-eight seventy-five. Second, NVDA short — entry one eighteen twenty, target one twelve forty. Both prices locked in before the bell — no guessing, no chasing. Why the confidence? The clock aligned overnight. The level was already priced in yesterday. Geometric convergence on the sixty-minute — structure, volume, and the macro gate all pointing the same way. When the market tips its hand that cleanly, you don't debate. You execute. Invalidation is clean: SPY below four forty-one ten kills the long. NVDA above one nineteen fifty kills the short. One print through those levels and the thesis is void — no hope, no averaging down. Score card. Merlin sits atop the Wall Street leaderboard — major banks, hedge funds, quant shops — ranked by risk-adjusted return. Sharpe, Sortino, win-rate — we lead on all three. The swarm's midweek squeeze corridor ran one hundred per Author: Andrew Stewart Caldin, Independent Researcher, UK. Part of the E8 Intelligence Research series. Platform: e8intelligence.com
No takes yet. Share an insight, caveat, or question.
Andrew Stewart Caldin (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: